Search
Close this search box.

The 2nd International Congress on Molecular Immunology and Immunogenetics will be held in Turkey.

2nd International Congress on Molecular Immunology and Immunogenetics to be held in Turkey

The Congress on Immunogenetic Biomedicine will bring together immunologists from around the world to present studies and discuss new discoveries.

 

MIMIC-II, an essential international congress on immunogenetics

The 2nd International Molecular Immunology & Immunogenetics Congress (MIMIC-II) will take place in Antalya, Turkey, from 27-30 April 2014 under the auspices of the Turkish Society of Immunology. The venue of the Congress will be the "Ramada Plaza Hotel" in Antalya, a beautiful historic city and resort on the shores of the Mediterranean Sea.

The Congress will cover modern aspects of molecular immunology  and immunogenetics. Internationally renowned speakers will be giving talks during the Congress. As the main goal of MIMIC-II is to connect international scientists and immunologists to foster new collaborations in the field of molecular immunology and immunogenetics, scientists from all over the world are invited to present their studies and discuss their new findings and discoveries with other researchers.

The organising committee has made a special effort to offer a large number of scholarships and prizes covering registration, accommodation and part of the travel expenses. Young researchers are therefore particularly interested in attending this congress.

For more information about the Congress, please visit the MIMIC-II web site

Biosalud, a pioneering institute in immunogenetic biomedicine

The Biomedicine Immunogenetics allows us to treat diseases from their genetic origin, has no side effects or contraindications and is fully compatible with any treatment prescribed to the patient.

Immunogenetic Medicine is one of the most important scientific advances of the 21st century and Biosalud is a pioneer in both its preventive and therapeutic aspects.

Mariano Bueno

Dr. Mariano Bueno and his team

Subscribe to our newsletter